Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Intestinal Microbiota-based Product for Preventing Type 2 Diabetes Mellitus

NCT04495972 is registered in ClinicalTrials.gov with Caelus Pharmaceuticals BV as lead sponsor.

NCT NCT04495972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04495972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Intestinal Microbiota-based Product for Preventing Type 2 Diabetes Mellitus
Lead sponsor
Caelus Pharmaceuticals BV
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2021
Completion date
November 10, 2023
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prediabetes